116 related articles for article (PubMed ID: 23467623)
21. Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines.
Yamaguchi N; Ito T; Azuma S; Ito E; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Watanabe S; Semba K; Inoue J
Cancer Sci; 2009 Sep; 100(9):1668-74. PubMed ID: 19538528
[TBL] [Abstract][Full Text] [Related]
22. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
[TBL] [Abstract][Full Text] [Related]
23. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
[TBL] [Abstract][Full Text] [Related]
24. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
[TBL] [Abstract][Full Text] [Related]
25. Distribution of molecular breast cancer subtypes among Tunisian women and correlation with histopathological parameters: a study of 194 patients.
Ben Abdelkrim S; Trabelsi A; Missaoui N; Beizig N; Bdioui A; Anjorin A; Jomaa W; Mokni M
Pathol Res Pract; 2010 Nov; 206(11):772-5. PubMed ID: 20850937
[TBL] [Abstract][Full Text] [Related]
26. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
[TBL] [Abstract][Full Text] [Related]
27. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation in histologically distinct classes of breast cancer.
Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
[TBL] [Abstract][Full Text] [Related]
29. [The significance of methylation status of secreted frizzled-related protein gene promoter in acute leukemia].
Xu CB; Shen JZ; Shen SF; Fu HY; Zhu YF; Chen L
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):769-71. PubMed ID: 21092449
[TBL] [Abstract][Full Text] [Related]
30. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
Recăreanu F; Simionescu C; Georgescu CV; Pirici E
Rom J Morphol Embryol; 2011; 52(3 Suppl):1059-64. PubMed ID: 22119825
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin expression in molecular types of breast carcinoma.
Ionescu Popescu C; Giuşcă SE; Liliac L; Avadanei R; Ceauşu R; Cîmpean AM; Balan R; Amălinei C; Ciobanu Apostol D; Căruntu ID
Rom J Morphol Embryol; 2013; 54(2):267-73. PubMed ID: 23771069
[TBL] [Abstract][Full Text] [Related]
32. Basal-like breast cancer displays distinct patterns of promoter methylation.
Lee JS; Fackler MJ; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Sukumar S
Cancer Biol Ther; 2010 Jun; 9(12):1017-24. PubMed ID: 20505321
[TBL] [Abstract][Full Text] [Related]
33. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.
Wang S; Dorsey TH; Terunuma A; Kittles RA; Ambs S; Kwabi-Addo B
PLoS One; 2012; 7(5):e37928. PubMed ID: 22701537
[TBL] [Abstract][Full Text] [Related]
34. Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer.
Dong DD; Yie SM; Li K; Li F; Xu Y; Xu G; Song L; Yang H
Hum Immunol; 2012 Oct; 73(10):998-1004. PubMed ID: 22841927
[TBL] [Abstract][Full Text] [Related]
35. Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.
Mujtaba SS; Ni YB; Tsang JY; Chan SK; Yamaguchi R; Tanaka M; Tan PH; Tse GM
Ann Surg Oncol; 2013 Sep; 20(9):2842-9. PubMed ID: 23539156
[TBL] [Abstract][Full Text] [Related]
36. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
37. Identification of a basal-like subtype of breast ductal carcinoma in situ.
Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
[TBL] [Abstract][Full Text] [Related]
38. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Kawajiri H; Ogawa Y; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
Br J Surg; 2013 Mar; 100(4):490-6. PubMed ID: 23319435
[TBL] [Abstract][Full Text] [Related]
39. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]